Gr. Sarantis S.a. · ATHEX:SAR

Gr. Sarantis — Sarantis Group — Investor Presentation (January 2026)

33 slides from Gr. Sarantis's investor presentation, January 2026

  1. Slide 1: Sarantis Group Investors Presentation January 2026

    Sarantis Group Investors Presentation January 2026

  2. Slide 2: Forward-looking statement

    Forward-looking statement This document contains certain “forward-looking” statements. These statements may generally, but not always, be identified by the use of words such as “outlook”, “forecast”, “objective”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “target”, “will”, “aim” and other

  3. Slide 3: With you today

    With you today Giannis Bouras Christos Varsos Group Chief Executive Officer Group Chief Financial Officer 3 Sarantis Group Investors Presentation

  4. Slide 4: Strategic Overview

    Strategic Overview Giannis Bouras, Group Chief Executive Officer

  5. Slide 5: A long history of over 60 years

    A long history of over 60 years 2015 Milestone acquisitions: 1964 Establishment of 1994 New production facilities Polipak, Ergopack, Stella GR. SARANTIS S.A. 2000 in Athens 2024 Pack Expansion in Eastern Investments in Europe infrastructure New exclusive strategic agreements Intense Acquisition List

  6. Slide 6: We care for the future the same way we care about the present

    We care for the future the same way we care about the present OUR COMPETITIVE ADVANTAGE OUR SCOPE ▪ We design for the CEE region with deep local consumer understanding ▪ CEE and selected international markets on beauty ▪ We are the revitalisers of local “jewel” brands ▪ Home Care solutions ▪ We inve

  7. Slide 7: Consistent organic growth with acquisitions coming on top

    Consistent organic growth with acquisitions coming on top Sarantis Group Growth Drivers Beauty, Skin & Personal Home Care Strategic Sun Care Care Solutions Partnerships Disproportionate Core Profit Significant growth driver Market leverage growth Generator Complementary acquisitions on top in key pr

  8. Slide 8: Accelerating our international expansion momentum

    Accelerating our international expansion momentum Expansion of international markets portfolio Growth Drivers for Exports USA #1 in Tanning Category at Oils and Lotions Beauty, Skin & Suncare in Amazon US #100 in Beauty and Personal Care Category in Amazon US (among 70,000+ brands) Launched with phy

  9. Slide 9: Executing our strategic transformation agenda

    Executing our strategic transformation agenda DIGITAL TRANSFORMATION MANUFACTURING UPGRADE ESG ▪ New SAP implementation: Building a ▪ Stella Pack regranulation upgrade unified data platform across markets ▪ Validate near-term climate targets completed in 2025 to drive efficiency, o Go-live of first

  10. Slide 10: Well-placed for Sustainable Growth

    Well-placed for 10 Sustainable Growth *Net Sales €740m 2X EBITDA to €120m *EBITDA €100m 2X EBIT to €95m *EBITDA €90.3m EBIT €77m Net Sales €600.1m EBIT €67.6m Net Sales €482.2m EBITDA €81.6m from 2023 Net Sales €445.1m EBITDA €61.6m EBIT €61.0m EBITDA €45.5m EBIT €47.1m EBIT €32.2m √ 2022 2023 2024

  11. Slide 11: Financial Performance

    Financial Performance Christos Varsos, Group Chief Financial Officer

  12. Slide 12: Solid nine-month performance with continued profitability growth

    Solid nine-month performance with continued profitability growth 9m 2025 Net Sales € 448.5m - 0.8%* *Net sales impacted by the sale of Stella Pack Ukraine: like-for-like variance: -0.3% 9m 2025 EBITDA 9m 2025 EBIT Robust Financial Position € 68.0m € 51.7m Net debt € 4.9m + 7.9% + 7.4% as of Septembe

  13. Slide 13: H1 2025 solid sales with strong delivery in profitability

    H1 2025 solid sales with strong delivery in profitability Consolidated Statement of Comprehensive income Amounts In €m H1 2025 H1 2024 Δ (unless otherwise stated) Net Sales 304.3 302.6 0.5% Gross Profit 117.5 116.8 0.6% Gross Profit margin 38.6% 38.6% EBITDA 48.3 41.7 15.7% EBITDA margin 15.9% 13.8%

  14. Slide 14: Strong profitability in strategic growth category, rebalancing Private Label portfolio

    Strong profitability in strategic growth category, rebalancing Private Label portfolio H1 2025 figures NET SALES EBIT EBIT % % Δ y-o-y % Δ y-o-y Δ y-o-y Beauty, Skin € 55.0m € 15.9m 28.9% & Sun Care + 22.7% + 71.6% + 824bps Personal € 50.7m € 8.5m 16.7% Care - 3.5% + 13.3% + 248bps Home Care € 101.7

  15. Slide 15: Strong growth in key markets while navigating a mixed consumer environment

    Strong growth in key markets while navigating a mixed consumer environment H1 2025 figures NET SALES EBIT EBIT% %Δ y-o-y %Δ y-o-y Δ y-o-y NET SALES EBIT EBIT% %Δ y-o-y %Δ y-o-y Δ y-o-y € 97.6m € 19.3m 19.8% Greece € 97.6m € 19.3m 19.8% + 9.9% + 56.0% + 585bps Greece + 9.9% + 56.0% + 585bps € 89.9m €

  16. Slide 16: Strong balance sheet

    Strong balance sheet ▪ Balance sheet empowers financial strength and flexibility to ▪ invest organically ▪ support the transformation of the Group ▪ fuel M&A activity ▪ Strong financial position with net debt of €4.9m as of 30.09.2025, compared to €32.8m as of 30.06.2025 and €12.4m as of 30.09.2024

  17. Slide 17: Enhancing shareholders value

    Enhancing shareholders value Dividend paid in May 2025 €20.0m (+33.3% to PY) €0.31 per share EPS €0.4575 Dividend payout ratio 43.5% per share (vs 38.2% in the PY) (+ 22.2%) Share buy-back Cancelation of program treasury stocks in place as of June 19th, 2025 17 Sarantis Group Investors Presentation

  18. Slide 18: CAPEX Execution Plan with increased investment from 2025

    CAPEX Execution Plan with increased investment from 2025 Capex 2024 2025 2026 2027 2028 Oinofyta DC* € 1.5m € 23.5m Digital* € 4.0m € 3.0m € 6.0m transformation Stella € 3.0m € 15.0m € 3.0m € 2.0m € 2.0m Rest of Group € 8.5m € 14.0m € 6.0m € 6.0m € 6.0m Total € 17.5m € 34.5m € 35.5m € 8.0m € 8.0m 5-

  19. Slide 19: Delivering Strong Shareholder Value

    Delivering Strong Shareholder Value 5-Year Plan* *as communicated during the Investor Day in March 2024

  20. Slide 20: Disproportional growth on Beauty, Skin & Sun Care

    Disproportional growth on Beauty, Skin & Sun Care CAGR Net Sales (€m) 2023 2024* 2025 2026 2027 2028 2023-2028 Own brands 349.6 454.3 481.7 509.0 537.7 568.7 10.2% Beauty, Skin & Sun Care 48.2 57.2 70.0 77.7 87.1 99.7 15.7% Personal Care 102.8 108.1 112.7 120.1 127.8 134.9 5.6% Home Care 198.7 288.9

  21. Slide 21: Doubling the EBITDA Organically in the next 5 years

    Doubling the EBITDA Organically in the next 5 years (€m) 2023 2024* 2025 2026 2027 2028 Net Sales 482.2 595.2 627.9 662.5 698.9 737.4 %YoY 23.5% 5.5% 5.5% 5.5% 5.5% Gross Margin 182.0 225.1 239.3 254.5 270.6 287.6 % on NS 37.8% 37.8% 38.1% 38.4% 38.7% 39.0% A&P 28.6 33.9 37.2 40.6 41.5 42.4 % on NS

  22. Slide 22: Why Sarantis has a strong Investment Case

    Why Sarantis has a strong Investment Case ▪ Sustainable organic growth engine 01 ▪ Leading presence in our geographies ▪ Strong brand portfolio in the right categories ▪ Strong supply chain footprint with continuous investment plan 2X EBITDA in 5 years from 2023 ▪ 02 ▪ Consistent dividend > 38% payo

  23. Slide 23: ESG Strategy

    ESG Strategy

  24. Slide 24: Raising Corporate Governance Standards

    Raising Corporate Governance Standards Strengthening Board Independence & All Committees comprise of Non-Executive Directors and are Gender Diversity chaired by Independent Non-Executive directors. Michalis Imellos New Eight-member Board of Directors as of 17.12.2025 Audit Committee Independent Non-

  25. Slide 25: Committing to Science-Based Targets initiative (SBTi)-aligned targets

    Committing to Science-Based Targets initiative (SBTi)-aligned targets We align our strong financial performance with measurable sustainability initiatives that drive business value 2023 2026 2027 2030 2050 we commit to setting a we commit to Net-zero mid-term CO2 scope 3 carbon footprint across the

  26. Slide 26: ESG Performance: Ratings & Assessments

    ESG Performance: Ratings & Assessments Improved to Medium Risk category (from High Risk previously) Overall risk improved to Medium (from High previously), with strongest progress in Governance ESG ratings improving supported by business plan execution and ongoing engagement with ESG raters CDP 2024

  27. Slide 27: Appendix

    Appendix

  28. Slide 28: Our brands

    Our brands Beauty, Skin & Sun Care Personal Care

  29. Slide 29: Our brands – Home Care Solutions

    Our brands – Home Care Solutions

  30. Slide 30: Strategic Partnerships – Mass Distribution

    Strategic Partnerships – Mass Distribution

  31. Slide 31: Strategic Partnerships – Selective Distribution

    Strategic Partnerships – Selective Distribution Premium/ Niche brands

  32. Slide 32: Recent Acquisitions

    Recent Acquisitions 2014 2015 2015 2018 2018 2020 2024 Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition ✓ Cosmetics brand ✓ Hand-dishwashing ✓ Production of PL ✓ Cosmetics brand ✓ Leading player in the ✓ Cosmetics br

  33. Slide 33: Q&A

    Q&A For further information on Sarantis Group please visit our website at https://sarantisgroup.com/ or contact our Investor Relations team: Eleni Moustakidou Investor Relations Manager emoustakidou@sarantisgroup.com +30 210 6173065

Sarantis Group — Investor Presentation (January 2026) on 6ix